A
Arcturus Therapeutics Holdings Inc.
ARCT · NASDAQ · Healthcare · 234M
Closing price
$13.74
+6.76% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.8×
Enterprise value / EBITDAEV/EBITDA
-2.7×
Free cash flow yieldFCF yield
-19.7%
Return on equityROE
-30.7%
Operating margin
-111.5%
Net debt / EBITDAbalance-sheet strength
3.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.